Glenmark Life Sciences Ltd logo

GLS

Glenmark Life Sciences Ltd

$0.16

Earnings Summary

Revenue
$0.03Mn
Net Profits
$43.63Mn
Net Profit Margins
169427.68%

Highlights

Revenue:

Glenmark Life Sciences Ltd’s revenue fell -99.77% since last year same period to $0.03Mn in the Q4 2022. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated 287.12% jump in its revenue since last 3-months.

Net Profits:

Glenmark Life Sciences Ltd’s net profit jumped 146.55% since last year same period to $43.63Mn in the Q4 2022. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated 306727.06% jump in its net profits since last 3-months.

Net Profit Margins:

Glenmark Life Sciences Ltd’s net profit margin jumped 20319.67% since last year same period to 169427.68% in the Q4 2022. On a quarterly growth basis, Glenmark Life Sciences Ltd has generated 79306.75% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Glenmark Life Sciences Ltd post its latest quarter earnings

EPS Estimate Current Quarter
-0.26
EPS Estimate Current Year
-0.26

Highlights

EPS Estimate Current Quarter:

Glenmark Life Sciences Ltd’s earning per share (EPS) estimates for the current quarter stand at -0.26 - a 23.53% jump from last quarter’s estimates.

EPS Estimate Current Year:

Glenmark Life Sciences Ltd’s earning per share (EPS) estimates for the current year stand at -0.26.

Key Ratios

Key ratios of the Glenmark Life Sciences Ltd post its Q4 2022 earnings

Return on Assets (ROA)
-0.61
Return on Equity (ROE)
-5.52

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Glenmark Life Sciences Ltd’s return on assets (ROA) stands at -0.61.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Glenmark Life Sciences Ltd’s return on equity (ROE) stands at -5.52.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-11-14
-0.34
-0.2
41.18%